Authors:
Para, MF
Meehan, P
Holden-Wiltse, J
Fischl, M
Morse, G
Shafer, R
Demeter, LM
Wood, K
Nevin, T
Virani-Ketter, N
Freimuth, WW
Citation: Mf. Para et al., ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy, ANTIM AG CH, 43(6), 1999, pp. 1373-1378
Authors:
Gulick, RM
McAuliffe, V
Holden-Wiltse, J
Crumpacker, C
Liebes, L
Stein, DS
Meehan, P
Hussey, S
Forcht, J
Valentine, FT
Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514